O	0	8	Dramatic
B-intervention	9	16	dietary
I-intervention	17	20	fat
I-intervention	21	30	reduction
O	31	33	is
O	34	42	feasible
O	43	46	for
O	47	53	breast
O	54	60	cancer
O	61	69	patients
O	69	70	:
O	71	78	Results
O	79	81	of
O	82	85	the
O	86	96	randomised
O	97	102	study
O	102	103	,
O	104	108	WINS
O	109	110	(
B-location	110	112	UK
O	112	113	)
O	114	115	-
O	116	121	stage
O	122	123	1
O	123	124	.

O	125	128	The
O	129	138	influence
O	139	141	of
O	142	149	dietary
O	150	153	fat
O	154	156	on
O	157	163	breast
O	164	170	tumour
O	171	177	growth
O	177	178	(
O	178	179	1
O	179	180	)
O	181	184	and
O	184	185	,
O	186	190	more
O	191	199	recently
O	199	200	,
O	201	203	on
O	204	213	treatment
O	214	222	outcomes
O	222	223	,
O	223	224	(
O	224	225	2
O	225	226	,
O	226	227	3
O	227	228	)
O	229	237	suggests
O	238	240	an
O	241	250	important
O	251	255	role
O	256	259	for
O	260	267	dietary
O	268	274	advice
O	275	277	in
O	278	281	the
O	282	288	future
O	289	295	health
O	296	298	of
O	299	305	breast
O	306	312	cancer
O	313	321	patients
O	321	322	.

O	323	326	The
O	327	332	Women
O	332	333	'
O	333	334	s
O	335	347	Intervention
O	348	357	Nutrition
O	358	363	Study
O	364	365	(
O	365	367	UK
O	367	368	)
O	369	370	-
O	371	376	Stage
O	377	378	1
O	379	387	assessed
O	388	391	the
O	392	403	feasibility
O	404	406	of
O	407	416	achieving
O	417	420	and
O	421	432	maintaining
O	433	434	a
O	435	436	≥
O	437	439	50
O	439	440	%
O	441	450	reduction
O	451	453	in
O	454	462	reported
O	463	466	fat
O	467	473	intake
O	474	476	in
B-eligibility	477	491	postmenopausal
I-eligibility	491	492	,
I-eligibility	493	498	early
I-eligibility	499	504	stage
I-eligibility	505	511	breast
I-eligibility	512	518	cancer
I-eligibility	519	527	patients
I-eligibility	528	530	in
I-eligibility	531	534	the
I-eligibility	535	537	UK
O	537	538	.

O	539	543	This
O	544	549	study
O	550	559	recruited
O	560	568	patients
O	569	571	in
B-location	572	577	South
I-location	577	578	-
I-location	578	582	east
I-location	583	590	England
O	591	598	between
O	599	603	2000
O	604	607	and
O	608	612	2005
O	612	613	.

O	614	618	They
O	619	623	were
O	624	632	randomly
O	633	642	allocated
O	643	647	into
O	648	651	two
O	652	658	groups
O	658	659	.

O	660	665	Group
O	666	667	1
O	668	669	(
O	669	670	n
O	671	672	=
B-intervention-participants	673	675	54
O	675	676	)
O	676	677	,
O	678	686	received
O	687	695	specific
O	696	703	dietary
O	704	715	counselling
O	716	718	to
O	719	724	halve
O	725	730	their
O	731	739	reported
O	740	743	fat
O	744	750	intake
O	751	754	and
O	755	763	maintain
O	764	768	this
O	769	772	low
O	773	776	fat
O	777	783	intake
O	783	784	.

O	785	790	Group
O	791	792	2
O	793	794	(
O	794	795	n
O	796	797	=
B-control	798	800	53
O	800	801	)
O	802	810	received
B-control	811	818	healthy
I-control	819	825	eating
I-control	826	832	advice
I-control	833	837	only
O	837	838	.

O	839	848	Dietitian
O	848	849	-
O	849	852	led
O	853	858	group
O	859	867	sessions
O	868	876	provided
O	877	884	support
O	885	888	for
O	889	894	women
O	895	897	in
O	898	902	both
O	903	909	groups
O	910	914	over
O	915	916	2
O	917	922	years
O	922	923	.

O	924	925	(
O	925	926	4
O	926	927	)
O	928	937	Validated
O	938	942	four
O	942	943	-
O	943	946	day
O	947	954	diaries
O	955	959	were
O	960	964	used
O	965	967	to
O	968	975	measure
O	976	982	intake
O	982	983	.

O	984	988	Data
O	989	997	analysis
O	998	1002	used
O	1003	1014	Generalised
O	1015	1021	Linear
O	1022	1027	Model
O	1028	1029	(
O	1029	1032	GLM
O	1032	1033	)
O	1034	1037	for
O	1038	1046	repeated
O	1047	1055	measures
O	1056	1059	and
O	1060	1068	logistic
O	1069	1079	regression
O	1079	1080	.

O	1081	1082	A
O	1083	1096	significantly
O	1097	1104	greater
O	1105	1115	proportion
O	1116	1118	of
O	1119	1124	women
O	1125	1127	in
O	1128	1133	Group
O	1134	1135	1
O	1136	1144	reported
O	1145	1146	a
B-outcome	1147	1150	fat
I-outcome	1151	1157	intake
I-outcome	1158	1167	reduction
O	1168	1170	of
O	1171	1172	≥
O	1173	1175	50
O	1175	1176	%
O	1177	1179	at
O	1180	1181	3
O	1182	1188	months
O	1189	1190	(
O	1190	1191	p
O	1192	1193	<
O	1194	1195	.
O	1195	1198	001
O	1198	1199	)
O	1200	1203	and
O	1204	1206	24
O	1207	1213	months
O	1214	1215	(
O	1215	1216	p
O	1217	1218	<
O	1219	1220	.
O	1220	1223	001
O	1223	1224	)
O	1225	1229	than
O	1230	1232	in
O	1233	1238	Group
O	1239	1240	2
O	1240	1241	.

O	1242	1245	The
B-outcome	1246	1250	size
I-outcome	1251	1253	of
I-outcome	1254	1257	the
I-outcome	1258	1264	effect
I-outcome	1265	1267	of
I-outcome	1268	1274	active
I-outcome	1275	1282	dietary
I-outcome	1283	1294	counselling
O	1295	1298	was
B-iv-bin-percent	1299	1301	37
I-iv-bin-percent	1301	1302	%
B-outcome	1303	1305	at
I-outcome	1306	1307	3
I-outcome	1308	1314	months
O	1315	1316	(
O	1316	1318	95
O	1318	1319	%
O	1319	1321	CI
O	1321	1322	:
O	1323	1325	21
O	1325	1326	-
O	1326	1328	54
O	1328	1329	%
O	1329	1330	)
O	1331	1334	and
B-iv-bin-percent	1335	1337	35
I-iv-bin-percent	1337	1338	%
B-outcome	1339	1341	at
I-outcome	1342	1344	24
I-outcome	1345	1351	months
O	1352	1353	(
O	1353	1355	95
O	1355	1356	%
O	1356	1358	CI
O	1358	1359	:
O	1360	1362	17
O	1362	1363	-
O	1363	1365	53
O	1365	1366	%
O	1366	1367	)
O	1367	1368	.

B-outcome	1369	1373	Mean
I-outcome	1374	1377	fat
I-outcome	1378	1384	intake
O	1385	1388	was
O	1389	1395	halved
O	1396	1398	at
O	1399	1400	3
O	1401	1407	months
O	1408	1411	and
O	1412	1414	24
O	1415	1421	months
O	1422	1424	in
O	1425	1430	Group
O	1431	1432	1
O	1433	1437	only
O	1437	1438	.

O	1439	1452	Demonstrating
O	1453	1457	such
O	1458	1469	feasibility
O	1470	1472	is
O	1473	1474	a
O	1475	1478	key
O	1479	1483	step
O	1484	1491	towards
O	1492	1500	defining
O	1501	1505	diet
O	1505	1506	'
O	1506	1507	s
O	1508	1512	role
O	1513	1515	in
O	1516	1519	the
O	1520	1529	secondary
O	1530	1540	prevention
O	1541	1543	of
O	1544	1550	breast
O	1551	1557	cancer
O	1557	1558	.
